Cyclo Therapeutics Stock Price on October 28, 2024
| CYTH Stock | USD 0.64 0.08 11.11% |
Below is the normalized historical share price chart for Cyclo Therapeutics extending back to October 26, 1994. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cyclo Therapeutics stands at 0.64, as last reported on the 30th of November, with the highest price reaching 0.72 and the lowest price hitting 0.64 during the day.
If you're considering investing in Cyclo Stock, it is important to understand the factors that can impact its price. Cyclo Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0178, which signifies that the company had a -0.0178% return per unit of standard deviation over the last 3 months. Cyclo Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cyclo Therapeutics' risk adjusted performance of (0.03), and Mean Deviation of 3.48 to double-check the risk estimate we provide.
As of now, Cyclo Therapeutics' Common Stock is decreasing as compared to previous years. The Cyclo Therapeutics' current Capital Stock is estimated to increase to 3,500, while Total Stockholder Equity is projected to decrease to under 2.6 M. . As of now, Cyclo Therapeutics' Price Sales Ratio is increasing as compared to previous years. The Cyclo Therapeutics' current Price Fair Value is estimated to increase to 7.66, while Price Earnings Ratio is projected to decrease to (1.36). Cyclo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date | 200 Day MA 1.1397 | 50 Day MA 0.7298 | Beta (0.38) |
Cyclo |
Sharpe Ratio = -0.0178
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CYTH |
Estimated Market Risk
| 4.6 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cyclo Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cyclo Therapeutics by adding Cyclo Therapeutics to a well-diversified portfolio.
Price Book 59.1038 | Enterprise Value Ebitda (0.47) | Price Sales 18.2908 | Shares Float 15.9 M | Wall Street Target Price 0.95 |
Cyclo Therapeutics Main Headline on 28th of October 2024
Short Interest in Cyclo Therapeutics, Inc. Declines By 21.9 by thelincolnianonline.com
Cyclo Therapeutics, Inc. was the target of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 130,500 shares, a drop of 21.9 percent from the September 30th total of 167,200 shares. Approximately 0.8 percent of the companys shares are short sold.
Cyclo Therapeutics Valuation on October 28, 2024
It is possible to determine the worth of Cyclo Therapeutics on a given historical date. On October 28, 2024 Cyclo was worth 0.77 at the beginning of the trading date compared to the closed value of 0.73. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cyclo Therapeutics stock. Still, in general, we apply an absolute valuation method to find Cyclo Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cyclo Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cyclo Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.74 | 0.78 | 0.73 | 0.75 | 13,313 | |
10/28/2024 | 0.77 | 0.78 | 0.72 | 0.73 | 67,588 |
| 0.76 | 0.76 | 0.74 | 0.75 | 2,584 |
| Backtest Cyclo Therapeutics | | | Cyclo Therapeutics History | | | Cyclo Therapeutics Valuation | Previous | Next |
Cyclo Therapeutics Trading Date Momentum on October 28, 2024
| On October 29 2024 Cyclo Therapeutics was traded for 0.75 at the closing time. The top price for the day was 0.76 and the lowest listed price was 0.74 . The trading volume for the day was 2.6 K. The trading history from October 29, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 2.74% . The overall trading delta against the current closing price is 4.11% . |
Cyclo Therapeutics Fundamentals Correlations and Trends
By evaluating Cyclo Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cyclo Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cyclo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cyclo Therapeutics Stock history
Cyclo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cyclo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cyclo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cyclo Therapeutics stock prices may prove useful in developing a viable investing in Cyclo Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 16.3 M | 17.1 M | |
| Net Loss | -13.9 M | -13.2 M |
Cyclo Therapeutics Stock Technical Analysis
Cyclo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cyclo Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Cyclo Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cyclo Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Cyclo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cyclo Therapeutics shares will generate the highest return on investment. By undertsting and applying Cyclo Therapeutics stock market strength indicators, traders can identify Cyclo Therapeutics entry and exit signals to maximize returns
Cyclo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cyclo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cyclo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cyclo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (1.02) | |||
| Treynor Ratio | (4.63) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cyclo Stock analysis
When running Cyclo Therapeutics' price analysis, check to measure Cyclo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclo Therapeutics is operating at the current time. Most of Cyclo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cyclo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclo Therapeutics' price. Additionally, you may evaluate how the addition of Cyclo Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |